GL-261-LUC

GL261 Luciferase Cell Line engineered for stable, high-efficiency expression of the luciferase gene.This advanced tool delivers exceptionally high imaging quality and precise, quantifiable luminescence, ensuring your data is both robust and publication-ready.
Designed for versatility, the GL261 Luciferase Cell Line seamlessly adapts to a broad spectrum of applications—from promoter activity assays and mammalian two-hybrid studies to sophisticated in vivo imaging.
In 1939, GL261 tumor was induced by intracranial injection of 3-methylcholanthrene, cultured in C57BL/6 mice, and maintained through continuous transplantation into isogenic mouse strains. In the mid-1990s, in vitro growth cell cultures were established; literature describes cells carrying TP53 and KRAS mutations.